-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Brf7NZZx+bP2Q5LyemsaunCKLauMcRfDcCxhRlkZQjdCesZ5OA/ksk53qrypncHt 0CyDWQP71tJpIA1ygtRmxA== 0000950155-01-500116.txt : 20010911 0000950155-01-500116.hdr.sgml : 20010911 ACCESSION NUMBER: 0000950155-01-500116 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010910 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: V I TECHNOLOGIES INC CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-55237 FILM NUMBER: 1734720 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 5167527314 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NEW YORK BLOOD CENTER INC CENTRAL INDEX KEY: 0001079298 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 131949477 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 310 E 67TH STREET CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125703009 MAIL ADDRESS: STREET 1: 310 E 67TH STREET CITY: NEW YORK STATE: NY ZIP: 10021 SC 13G/A 1 e588181sch13g.txt SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* V.I. TECHNOLOGIES, INC. - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $.01 PAR VALUE - -------------------------------------------------------------------------------- (Title of Class of Securities) 917920100 ------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosure provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP NO. 917920100 - ---------- --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON New York Blood Center, Inc. 13-1949477 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP Not Applicable (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 2,359,704 shares SHARES ---------------------------------------------------------------- 6 SHARED VOTING POWER BENEFICIALLY None OWNED BY ---------------------------------------------------------------- EACH 7 SOLE DISPOSITIVE POWER REPORTING 2,359,704 shares PERSON ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER WITH None - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,359,704 shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* Not Applicable - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.5% (as of June 30, 2001) - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- ITEM 1. (a) Name of Issuer: V.I. Technologies, Inc. (b) Address of Issuer's Principal Executive Offices: 134 Coolidge Avenue Watertown, Massachusetts 02472 ITEM 2. (a) Name of Person Filing: New York Blood Center, Inc. (b) Address of Principal Business Office or, if none, Residence: 310 East 67th Street New York, New York 10021 (c) Citizenship: New York (d) Title of Class of Securities: Common Stock, $.01 par value (e) CUSIP Number: 917920100 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13-1(B), OR 13D-2(B), CHECK WHETHER THE PERSON FILING IS A: Not Applicable ITEM 4. OWNERSHIP (a) Amount beneficially owned 2,359,704 (b) Percent of class: 10.5% (as of June 30, 2001) (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 2,359,704 shares (ii) Shared power to vote or to direct the vote: None (iii) Sole power to dispose or to direct the disposition of: 2,359,704 shares (iv) Shared power to dispose or to direct the disposition of: None ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not Applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable ITEM 10. CERTIFICATION Not Applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. September 10, 2001 NEW YORK BLOOD CENTER, INC. By: /S/ LARRY HANNIGAN ------------------------------- Name: Larry Hannigan Title: Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----